Quarterly report pursuant to Section 13 or 15(d)

Cover

v3.22.4
Cover - shares
 9 Months Ended
Jan. 31, 2023
Mar. 16, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jan. 31, 2023  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --04-30  
Entity File Number 001-40699  
Entity Registrant Name PHARMACYTE BIOTECH, INC.  
Entity Central Index Key 0001157075  
Entity Tax Identification Number 62-1772151  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 3960 Howard Hughes Parkway  
Entity Address, Address Line Two Suite 500  
Entity Address, City or Town Las Vegas  
Entity Address, State or Province NV  
Entity Address, Postal Zip Code 89169  
City Area Code (917)  
Local Phone Number 595-2850  
Title of 12(b) Security Common Stock, Par Value $0.0001 Per Share  
Trading Symbol PMCB  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   17,443,385